BED BATH & BEYOND, INC.
For the period ended Sep 30, 2025. Filed Oct 27, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2025 · Filed Oct 27, 2025
NXH$1.36-9.9%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statements of Changes in Stockholders' Equity
| Bed Bath & Beyond, Inc.Consolidated Statements of Changes in Stockholders' Equity (Unaudited)(in thousands) | ||||
|---|---|---|---|---|
| Three months endedSeptember 30, | Nine months endedSeptember 30, | |||
| 2025 | 2024 | 2025 | 2024 | |
| Equity attributable to stockholders of Bed Bath & Beyond, Inc. | ||||
| Shares of common stock issued | ||||
| Balance at beginning of period | 64,322 | 52,230 | 59,560 | 51,770 |
| Common stock issued upon vesting of restricted stock | 2 | 6 | 341 | 410 |
| Common stock issued for ESPP purchases | 47 | 63 | 138 | 119 |
| Common stock sold through offerings | 8,100 | — | 12,432 | — |
| Balance at end of period | 72,471 | 52,299 | 72,471 | 52,299 |
| Shares of treasury stock | ||||
| Balance at beginning of period | 6,917 | 6,480 | 6,491 | 6,356 |
| Repurchases of common stock | 570 | — | 903 | — |
| Tax withholding upon vesting of employee stock awards | — | 2 | 93 | 126 |
| Balance at end of period | 7,487 | 6,482 | 7,487 | 6,482 |
| Total shares of common stock outstanding | 64,984 | 45,817 | 64,984 | 45,817 |
| Common stock | ||||
| Balance at beginning of period | $6 | $5 | $5 | $5 |
| Common stock sold through offerings | 1 | — | 2 | — |
| Balance at end of period | $7 | $5 | $7 | $5 |
| Additional paid-in capital | ||||
| Balance at beginning of period | $1,102,079 | $1,018,619 | $1,072,869 | $1,007,649 |
| Stock-based compensation to employees and directors | 3,522 | 6,349 | 8,002 | 16,384 |
| Common stock issued for ESPP purchases | 174 | 537 | 683 | 1,472 |
| Common stock sold through offerings, net | 77,467 | — | 101,688 | — |
| Balance at end of period | $1,183,242 | $1,025,505 | $1,183,242 | $1,025,505 |
| Accumulated deficit | ||||
| Balance at beginning of period | $(799,691) | $(598,177) | $(740,466) | $(481,671) |
| Net loss attributable to stockholders of Bed Bath & Beyond, Inc. | (4,521) | (61,030) | (63,746) | (177,536) |
| Balance at end of period | $(804,212) | $(659,207) | $(804,212) | $(659,207) |
| Accumulated other comprehensive loss | ||||
| Balance at beginning of period | $— | $(498) | $— | $(506) |
| Net other comprehensive income | — | 4 | — | 12 |
| Balance at end of period | $— | $(494) | $— | $(494) |
| Treasury stock | ||||
| Balance at beginning of period | $(171,526) | $(169,595) | $(169,676) | $(166,345) |
| Repurchases of common stock | (4,907) | — | (6,218) | — |
| Tax withholding upon vesting of employee stock awards | (5) | (21) | (544) | (3,271) |
| Balance at end of period | $(176,438) | $(169,616) | $(176,438) | $(169,616) |
| Total equity attributable to stockholders of Bed Bath & Beyond, Inc. | $202,599 | $196,193 | $202,599 | $196,193 |
| Continued on the following page | ||||
| Bed Bath & Beyond, Inc.Consolidated Statements of Changes in Stockholders' Equity (Unaudited)(in thousands) | ||||
|---|---|---|---|---|
| Three months endedSeptember 30, | Nine months endedSeptember 30, | |||
| 2025 | 2024 | 2025 | 2024 | |
| Equity attributable to noncontrolling interests | ||||
| Balance at beginning of period | $337 | $— | $— | $— |
| Proceeds from security token offering, net | 4 | — | 341 | — |
| Net loss attributable to noncontrolling interests | — | — | — | — |
| Total equity attributable to noncontrolling interests | $341 | $— | $341 | $— |
| Total stockholders' equity | $202,940 | $196,193 | $202,940 | $196,193 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.